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Abstract
Background—Single Balloon Enteroscopy (SBE) is a novel deep enteroscopy modality for 
diagnosis and treatment of disorders of the small bowel.
Objective—The aim of the study was to examine the performance, yield and safety of SBE in the 
initial experience at a tertiary care center.
Design—Retrospective analysis of all SBEs during a 10 month period in 2008. Data was 
extracted from electronic clinical and endoscopy records.
Setting—U.S. tertiary care center.
Patients—All patients referred for SBE were included in the current analysis.
Intervention—SBE.
Main Outcome Measurements—Anterograde SBE procedure time, diagnostic yield, and 
complications.
Results—Thirty-eight anterograde SBEs were performed. The mean age was 62 (42% female). 
Patients (97%) were referred for gastrointestinal bleeding, Crohn's disease, suspected polyps or 
neoplasia, and abnormal capsule endoscopy. The mean procedure time was 49 ± 19 minutes. The 
estimated depth of insertion: proximal jejunum (34%), mid-jejunum (45%), distal jejunum (21%). 
The SBE diagnostic yield was 47%, with significant findings in 18 patients. Findings included: 
angiectasias, bleeding, abnormal mucosa, ulceration, polyps, and foreign body. The therapeutic 
yield was 42%, with lesion ablation performed in 24%. Diagnostic biopsies were performed in 
24% of subjects, and tattooing in 52%. There were no significant complications.
Limitations—Single center retrospective study.
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Conclusions—Single balloon enteroscopy appears to be a safe and efficient method for 
examination of the mid-small bowel. The significant therapeutic yield (42%) suggests comparative 
studies with double balloon and spiral enteroscopy are warranted.
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Introduction
The advent of capsule endoscopy (CE) has accelerated the need to directly access the small 
intestine for therapeutic purposes. Push enteroscopy has limited depth of insertion, Sonde 
enteroscopy is of historical interest only, and intra-operative enteroscopy carries significant 
comorbidities.1, 2
The first deep enteroscopy technique, developed in 2001 in parallel with CE, was double 
balloon enteroscopy (DBE) which allows for complete enteroscopy in some patients.3 This 
technique has been disseminated among academic and high volume centers, yet remains 
limited by the following factors: the need for dedicated equipment, substantial operator 
learning curve, and prolonged procedure times.4-7
The single balloon enteroscope (SBE) was recently introduced as an additional method of 
examining the deep small bowel.8, 9 The system consists of an enteroscope, a flexible 
overtube with a balloon at the tip, and a processing unit. Initial reports indicate that SBE 
may offer several advantages over DBE, including ease of use and improved procedure time. 
There are also reports of using SBE to perform ERCP in patients with post-surgical 
anatomy.10 The purpose of this paper is to review our initial experience with SBE in a 
United States tertiary care center.
Methods
Patients
We performed a retrospective analysis of all SBEs performed at the University of North 
Carolina (UNC), a tertiary care referral center, during our initial experience with the device 
from February through December, 2008. Two reviewers independently identified cases. 
Patient and procedure characteristics were extracted from electronic medical records and the 
electronic endoscopy reporting system, ProVationMD®. Depth of insertion was based on 
the endoscopist report of the anatomic extent reached. We used anatomic regions because 
exact measurements were not consistently available. Any immediate complications were 
identified from the endoscopy report and nursing records, and admissions within 30 days of 
the procedure were reviewed for delayed complications. Recovery time was defined as 
interval between the time the procedure ended and the time the patient was discharged from 
the recovery area. This study was approved by the UNC IRB.
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The SBE system consists of an enteroscope, overtube, and balloon pressure control unit 
(Figure 1). The enteroscope (SIF-180, Olympus Corporation, PA) has a working length of 
200 cm, is 9.2 mm in diameter, and contains a 2.8 mm diameter working-channel. The 
disposable overtube (ST-SB1, Olympus Medical) is latex-free, hydrophobic, and has a 
balloon at the distal tip. The automatic pressure controlled inflation control unit (OBCU, 
Olympus Medical) allows on-demand inflation of the balloon. Endoscopes manufactured by 
other companies are compatible with the overtube, but the inflation control unit is required 
hardware.
SBE was performed by three endoscopists (DRM, ISG, ESD), who had no prior experience 
with DBE. Patients were placed in the left-lateral position and the SBE with overtube was 
introduced using standard technique.8, 9 In iterative fashion with the system positioned in the 
small bowel, the overtube is advanced to the tip of the enteroscope and the balloon is 
inflated, the enteroscope is advanced as far as possible, and then the overtube and 
enteroscope are partially withdrawn to reduce the small bowel, with or without enteroscope 
suction applied to the small bowel. This procedure is repeated to advance the scope as far as 
possible.11 In general, the procedure is a one physician procedure, with an endoscopy nurse 
or technician assisting with the overtube and balloon inflation. Conscious sedation with 
fentanyl and midazolam was used for the majority of cases.
Statistical analysis
Summary statistics were calculated using Stata version 9 (StataCorp, TX). Bivariate analysis 
was performed with either t-tests of chi-square, as appropriate.
Results
A total of 38 anterograde SBEs were performed during the study period. The mean age was 
62 ± 17, 58% male, and mean BMI 26 ± 6 (Table 1). The clinical indication in nearly all 
patients (97%) was obscure GI bleeding (Table 2). Eleven patients had abnormal capsule 
endoscopy studies (AVM’s (4), red spots (2), ulceration (3), denuded mucosa (1), 
subepithelial distortion (1), unspecified (1)). Other secondary indications included Crohn’s 
disease (n=3); abdominal pain (n=2); and suspected neoplasia (n=3).
The mean procedure time was 49 ± 19 minutes (range 25-105 minutes) (Table 2). Procedural 
time did not substantially vary based upon the experience of the endoscopist over the study 
period. Depth of insertion, as recorded by the endoscopist, was to the proximal jejunum in 
34% of procedures, to the mid-jejunum in 45%, and to the distal jejunum in 21%. Estimated 
distance past the ligament of Treitz was not routinely recorded. The mean medication doses 
used for conscious sedation were fentanyl 133 ± 59 mcg and midazolam 9 ± 4 mg. Adjuvant 
medications, when utilized, were promethazine (mean dose =16 ± 8 mg; n=8) and 
glucagon(mean dose = 0.3 ± 0.1 mg; n=16). General anesthesia was utilized in four cases 
(11%). The mean recovery time was 64 ± 44 minutes (range 29-230 minutes).
The overall SBE diagnostic yield was 47%, with significant findings in 18 patients (Figure 
2). These included: angiectasias or bleeding (n=10), abnormal mucosa or ulceration (n=7), 
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polyps (n=1), and retained capsule (n=1). The therapeutic yield was 42%, similar to the 
diagnostic yield. Argon plasma coagulation (APC) was performed in 24% of patients. 
Additional therapeutic interventions included hemostasis with epinephrine and clip 
application (n=2), polypectomy (n=1), dilatation (n=1), and foreign body removal (n=1). 
Diagnostic biopsies were performed in 24% of subjects, and tattooing of the depth of 
maximal insertion in 52%. Three retrograde SBEs successfully evaluated the distal ileum 
(depth of insertion range: 50-70 cm), but there were no significant findings. Importantly, 
there were no recorded complications of perforation, pancreatitis, hospitalization, or death.
Of the 37 antegrade procedures that had at least one indication for obscure bleeding, there 
were seven patients (19%) who had a rebleeding event in a 12-24 month follow-up period 
which required either hospitalization or repeat endoscopic evaluation over a . Four of these 
patients were found to have recurrent AVM bleeding that was able to be treated with SBE. 
Two patients bled from a cause which remained obscure. One patient did not have repeat 
endoscopic evaluation due to medical instability.
Discussion
The advent of capsule endoscopy has triggered the development of deep enteroscopy 
methods. Single balloon enteroscopy represents one emerging technique for deep 
enteroscopy, in parallel with DBE and spiral enteroscopy (SpE). In our initial experience 
reported herein, the diagnostic and therapeutic yields (47% and 42%, respectively) and 
average procedure time (49 minutes) compare favorably with the initial experience 
published for double balloon enteroscopy.7, 12 These results are also comparable to the 
initial reports of an SBE experience from Japan.8, 9 Occult GI bleeding and abnormal video 
capsule endoscopy were the primary indications for the procedures, with vascular lesion 
ablation as the primary intervention. The procedure was safe and well-tolerated with the use 
of conscious sedation (fentanyl, midazolam) for the majority of cases.
The SBE program was seamlessly incorporated into the tertiary care endoscopy program, 
one without prior DBE services. We note the rapid transition to a single physician procedure 
technique. We would expect the diagnostic and therapeutic yields to further improve with 
experience, but we do qualify our observations as this study represents a retrospective, 
single center analysis. Because of this, we had to rely on the content of endoscopy notes for 
estimated depth of insertion. We followed the methodology described by May and 
colleagues for DBE,13, 14 where after reaching maximal depth of insertion, serial 10 cm 
segments of small bowel are estimated on withdrawal until the angle of Treitz, and then 
summed to estimate of depth of insertion. However, since there was not consistent reporting 
of a measurement of depth of insertion in cm in our reports, we used the estimated anatomic 
region of depth reached which was present for all cases.
Another limitation of this report is that it focuses only on antegrade procedures. We had a 
limited preliminary experience with retrograde procedures (n = 3) during this time frame. 
All three cases were for occult bleeding with potential sources identified in the distal 
jejunum or ileum on prior CE; two patients had previously negative antegrade SpE. All three 
retrograde SBEs reached approximately 50-60 cm into the distal ileum, but there were no 
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definitive findings or therapeutic maneuvers. We felt that this approach proved more 
challenging, primarily due to traversal through the colon and the challenge of positioning the 
balloon and overtube in the terminal ileum, but are unable to draw conclusions with such a 
small sample size.
It is our belief that SBE has the potential to become a useful deep enteroscopy technique. 
Each of the three deep enteroscopy techniques feature advantages and disadvantages. SBE 
has reasonable depth of insertion, ability to use standard conscious sedation, use with 
existing endoscopy systems, and based on our experience, is easy to incorporate into an 
endoscopy unit and learn to use.8, 9, 15 DBE offers probable maximal depth of insertion and 
extensive supporting literature, balanced by the significant time investment.4, 7 Lastly, SpE 
is emerging in parallel with SBE, offering deep intubation with the efficient pleating 
approach, offset by the use of a larger overtube necessitating deeper sedation (e.g., 
propofol). 16, 17 The choice of which system to use will need to be individualized for each 
patient’s small bowel findings, as well as tailored to local expertise.
In conclusion, our initial experience with SBE is encouraging and portends increasing use 
for therapeutic and diagnostic small bowel enteroscopy. The procedure appears to be safe 
and relatively efficient, particularly in comparison to DBE. The significant therapeutic yield 
suggests that comparative studies with DBE and spiral enteroscopy are warranted.
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Single balloon enteroscope (9.2 mm diameter, 2.8 mm working-channel, 200 cm working-
length) and single balloon overtube (latex-free; deflated balloon seen here at the distal tip).
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Representative findings during SBE. (A) Telangiectasia > 75 cm from the ligament of 
Treitz, treated with argon plasma coagulation. (B) Polyp found > 90 cm from pylorus, 
treated by lift polypectomy. (C) Post-polypectomy view showing complete removal of 
polyp. Pathology revealed a hyperplastic polyp; the patient had known Peutz Jeghers 
Syndrome.
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Table 1
Patient Characteristics
Patient characteristics (n =38) Number (%) or mean
Mean age (years ± SD, range) 62 ± 17(19-85)
Median age 64
Sex:
  Female 16 (42)
  Males 22 (58)
Body Mass Index (BMI) 26 ±6
American Society of Anesthesiologists Classification (ASA)
  I: Normal 3(8)
  II: Mild Systemic Disease 24 (64)
  III: Severe Systemic Disease 11 (28)
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Table 2
Procedure Characteristics
Procedure Characteristics (n = 38) Number (%) or mean (± SD)
Time (minutes)
  Mean procedure time 49 ± 19
  Mean recovery time 64 ± 44
Estimated depth of insertion*
  Proximal jejunum 13 (34)
  Mid jejunum 17 (45)
  Distal jejunum 8 (21)
Conscious sedation mean doses
†
  Fentanyl (mcg) 133 ± 59
  Midazolam (mg) 9 ± 4
  Promethazine (mg; used in 8 patients) 16 ± 8
  Glucagon (mg; used in 11 patients) 0.3 ± 0.1
  Indication‡
  Gastrointestinal bleeding 37 (97)
  Nausea, vomiting, or weight loss 1 (3)
  Abnormal capsule endoscopy 11 (29)
  Suspected tumor 1 (3)
  Abdominal pain 2 (6)
  Crohn’s disease 3 (8)
  Celiac disease 1 (3)
  Suspected abscess 1 (3)
Diagnostic yield (small bowel findings seen in 18
patients) 
‡
  Angiectasias or bleeding 10 (56)
  Abnormal mucosa or ulceration 7 (39)
  Polyps 1 (6)
  Foreign body 1 (6)
  Stenosis 2 (12)
Therapeutic maneuvers (performed in 25 patients) 
‡
  Argon plasma coagulation 11 (44)
  Hemostasis (epinephrine or hemoclip) 2 (8)
  Polypectomy 1 (4)
  Dilation 1 (4)
  Foreign body removal 1 (4)
  Diagnostic biopsies 6 (24)




Estimated depth of insertion was determined retrospectively from endoscopist report.













Frantz et al. Page 12
†
Conscious sedation was administered to all patients except for 4 who received general anesthesia
‡
Total to more than 100% as more than 1 category per patient was allowed
#
Defined as respiratory depression, hypotension, cardiac arrhythmia, bleeding, pancreatitis, perforation, procedure-related hospitalizations, or 
death, as obtained from endoscopy reports and medical record review.
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